These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 34794002)
1. Site-specific construction of triptolide-based antibody-drug conjugates. Wei D; Mao Y; Xu Z; Chen J; Li J; Jiang B; Chen H Bioorg Med Chem; 2021 Dec; 51():116497. PubMed ID: 34794002 [TBL] [Abstract][Full Text] [Related]
2. Semisynthesis of triptolide analogues: effect of B-ring substituents on cytotoxic activities. Xu H; Chen Y; Tang H; Feng H; Li Y Bioorg Med Chem Lett; 2014 Dec; 24(24):5671-5674. PubMed ID: 25467158 [TBL] [Abstract][Full Text] [Related]
3. Antitumor and toxicity study of mitochondria-targeted triptolide derivatives using triphenylphosphine (TPP Song H; Xing W; Shi X; Zhang T; Lou H; Fan P Bioorg Med Chem; 2021 Nov; 50():116466. PubMed ID: 34700239 [TBL] [Abstract][Full Text] [Related]
4. Divinylsulfonamides enable the construction of homogeneous antibody-drug conjugates. Huang R; Sheng Y; Wei D; Lu W; Xu Z; Chen H; Jiang B Bioorg Med Chem; 2020 Dec; 28(23):115793. PubMed ID: 33039798 [TBL] [Abstract][Full Text] [Related]
5. Semisynthesis of triptolide analogues: effect of γ-lactone and C-14 substituents on cytotoxic activities. Aoyagi Y; Hitotsuyanagi Y; Hasuda T; Fukaya H; Takeya K; Aiyama R; Matsuzaki T; Hashimoto S Bioorg Med Chem Lett; 2011 May; 21(10):3046-9. PubMed ID: 21470864 [TBL] [Abstract][Full Text] [Related]
6. ATB Lou D; Lou Z; Lin Y; Shangguan H; Lin Y; Luo Q; Zhang H; Lin G; Chen R; Kou L; Bao S Bioorg Med Chem Lett; 2021 Feb; 33():127728. PubMed ID: 33346010 [TBL] [Abstract][Full Text] [Related]
7. Cryptophycin-55/52 based antibody-drug conjugates: Synthesis, efficacy, and mode of action studies. Lai Q; Wu M; Wang R; Lai W; Tao Y; Lu Y; Wang Y; Yu L; Zhang R; Peng Y; Jiang X; Fu Y; Wang X; Zhang Z; Guo C; Liao W; Zhang Y; Kang T; Chen H; Yao Y; Gou L; Yang J Eur J Med Chem; 2020 Aug; 199():112364. PubMed ID: 32402935 [TBL] [Abstract][Full Text] [Related]
8. Introducing Glycolinkers for the Functionalization of Cytotoxic Drugs and Applications in Antibody-Drug Conjugation Chemistry. Ekholm FS; Pynnönen H; Vilkman A; Pitkänen V; Helin J; Saarinen J; Satomaa T ChemMedChem; 2016 Nov; 11(22):2501-2505. PubMed ID: 27786414 [TBL] [Abstract][Full Text] [Related]
9. Antibody-Drug Conjugates (ADCs) Derived from Interchain Cysteine Cross-Linking Demonstrate Improved Homogeneity and Other Pharmacological Properties over Conventional Heterogeneous ADCs. Behrens CR; Ha EH; Chinn LL; Bowers S; Probst G; Fitch-Bruhns M; Monteon J; Valdiosera A; Bermudez A; Liao-Chan S; Wong T; Melnick J; Theunissen JW; Flory MR; Houser D; Venstrom K; Levashova Z; Sauer P; Migone TS; van der Horst EH; Halcomb RL; Jackson DY Mol Pharm; 2015 Nov; 12(11):3986-98. PubMed ID: 26393951 [TBL] [Abstract][Full Text] [Related]
10. Convergent synthesis of hydrophilic monomethyl dolastatin 10 based drug linkers for antibody-drug conjugation. Yang K; Chen B; Gianolio DA; Stefano JE; Busch M; Manning C; Alving K; Gregory RC; Brondyk WH; Miller RJ; Dhal PK Org Biomol Chem; 2019 Sep; 17(35):8115-8124. PubMed ID: 31460552 [TBL] [Abstract][Full Text] [Related]
11. Combined Treatment with Triptolide and Tyrosine Kinase Inhibitors Synergistically Enhances Apoptosis in Non-small Cell Lung Cancer H1975 Cells but Not H1299 Cells through EGFR/Akt Pathway. Tong X; Jiang P; Li Y; Guo L; Zhang HM; Zhang BK; Yan M Chem Pharm Bull (Tokyo); 2019 Aug; 67(8):864-871. PubMed ID: 31142691 [TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and anticancer activity evaluation of novel C14 heterocycle substituted epi-triptolide. Xu H; Tang H; Feng H; Li Y Eur J Med Chem; 2014 Feb; 73():46-55. PubMed ID: 24378709 [TBL] [Abstract][Full Text] [Related]
13. Chemical generation of small molecule-based bispecific antibody-drug conjugates for broadening the target scope. Yamaguchi A; Anami Y; Ha SYY; Roeder TJ; Xiong W; Lee J; Ueno NT; Zhang N; An Z; Tsuchikama K Bioorg Med Chem; 2021 Feb; 32():116013. PubMed ID: 33482584 [TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo evaluation of cysteine and site specific conjugated herceptin antibody-drug conjugates. Jackson D; Atkinson J; Guevara CI; Zhang C; Kery V; Moon SJ; Virata C; Yang P; Lowe C; Pinkstaff J; Cho H; Knudsen N; Manibusan A; Tian F; Sun Y; Lu Y; Sellers A; Jia XC; Joseph I; Anand B; Morrison K; Pereira DS; Stover D PLoS One; 2014; 9(1):e83865. PubMed ID: 24454709 [TBL] [Abstract][Full Text] [Related]
15. Triptolide and Its Derivatives as Cancer Therapies. Noel P; Von Hoff DD; Saluja AK; Velagapudi M; Borazanci E; Han H Trends Pharmacol Sci; 2019 May; 40(5):327-341. PubMed ID: 30975442 [TBL] [Abstract][Full Text] [Related]
16. LLDT-288, a novel triptolide analogue exhibits potent antitumor activity in vitro and in vivo. Xu H; Fan X; Zhang G; Liu X; Li Z; Li Y; Jiang B Biomed Pharmacother; 2017 Sep; 93():1004-1009. PubMed ID: 28724258 [TBL] [Abstract][Full Text] [Related]
17. Triptolide: Medicinal chemistry, chemical biology and clinical progress. Hou W; Liu B; Xu H Eur J Med Chem; 2019 Aug; 176():378-392. PubMed ID: 31121546 [TBL] [Abstract][Full Text] [Related]
18. Enhancement of triptolide-loaded micelles on tumorigenicity inhibition of human ovarian cancer. Wang Y; Liu T; Li H J Biomater Sci Polym Ed; 2016; 27(7):545-56. PubMed ID: 26786618 [TBL] [Abstract][Full Text] [Related]
19. Fluorination of triptolide and its analogues and their cytotoxicity. Aoyagi Y; Hitotsuyanagi Y; Hasuda T; Matsuyama S; Fukaya H; Takeya K; Aiyama R; Matsuzaki T; Hashimoto S Bioorg Med Chem Lett; 2008 Apr; 18(7):2459-63. PubMed ID: 18321701 [TBL] [Abstract][Full Text] [Related]
20. Total synthesis of novel D-ring-modified triptolide analogues: structure-cytotoxic activity relationship studies on the D-ring of triptolide. Zhou B; Li X; Tang H; Miao Z; Feng H; Li Y Org Biomol Chem; 2011 May; 9(9):3176-9. PubMed ID: 21409265 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]